Last reviewed · How we verify
NCT07105358: VIBRANT
Visual Plasticity Following Brain Lesions
NA trial testing transcranial random noise stimulation (tRNS) in Visual Field Defect in 30 participants. Currently enrolling.
30 June 2028
Quick facts
| Lead sponsor | Georgetown University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 17 July 2025 |
| Primary completion | 30 June 2028 |
| Estimated completion | 30 June 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- transcranial random noise stimulation (tRNS)
- Sham Stimulation
- Perceptual learning-based training
Conditions studied
- Visual Field Defect — all drugs for Visual Field Defect →
- Stroke — all drugs for Stroke →
- Hemianopia — all drugs for Hemianopia →
- Quadrantanopia — all drugs for Quadrantanopia →
Sponsor
Georgetown University
Who can join
18 and older, any sex, with Visual Field Defect or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual field loss resulting from damage to the post-chiasmatic visual pathways. It aims to investigate whether transcranial random noise stimulation (tRNS) combined with perceptual learning-based training has potential for improving visual impairments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07105358
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transcranial random noise stimulation (tRNS)
Trials testing the same drug.
- NCT06968689 — Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain · NA · recruiting
- NCT06155786 — Cognitive Effects of tDCS and tRNS in Schizophrenia · NA · completed
Other recruiting trials for Visual Field Defect
Currently open trials in the same condition.
- NCT06920290 — Visual Field Analysis With Artificial Intelligence · active not recruiting
Other Georgetown University trials
Trials by the same sponsor.
- NCT07228000 — Bundled Cancer Screening and Genetic Services Navigation · NA · not yet recruiting
- NCT07128927 — Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors · NA · recruiting
- NCT06046287 — Daratumumab for Polyneuropathy Associated With MGUS · Phase 2 · withdrawn
- NCT06980103 — Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyro · NA · recruiting
- NCT07418905 — Technology-supported Motor Rehabilitation for People With Rett Syndrome · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07105358 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Georgetown University
- Last refreshed: 5 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07105358.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing